132 related articles for article (PubMed ID: 24175830)
1. Stimulation of osteogenic differentiation in stromal cells of giant cell tumour of bone by zoledronic acid.
Yang T; Zheng XF; Li M; Lin X; Yin QS
Asian Pac J Cancer Prev; 2013; 14(9):5379-83. PubMed ID: 24175830
[TBL] [Abstract][Full Text] [Related]
2. Expression of preosteoblast markers and Cbfa-1 and Osterix gene transcripts in stromal tumour cells of giant cell tumour of bone.
Huang L; Teng XY; Cheng YY; Lee KM; Kumta SM
Bone; 2004 Mar; 34(3):393-401. PubMed ID: 15003787
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the anti-tumor effects of denosumab and zoledronic acid on the neoplastic stromal cells of giant cell tumor of bone.
Lau CP; Huang L; Wong KC; Kumta SM
Connect Tissue Res; 2013; 54(6):439-49. PubMed ID: 24060052
[TBL] [Abstract][Full Text] [Related]
4. A mouse model of luciferase-transfected stromal cells of giant cell tumor of bone.
Lau CP; Wong KC; Huang L; Li G; Tsui SK; Kumta SM
Connect Tissue Res; 2015 Nov; 56(6):493-503. PubMed ID: 26327464
[TBL] [Abstract][Full Text] [Related]
5. Bisphosphonates induce apoptosis of stromal tumor cells in giant cell tumor of bone.
Cheng YY; Huang L; Lee KM; Xu JK; Zheng MH; Kumta SM
Calcif Tissue Int; 2004 Jul; 75(1):71-7. PubMed ID: 15037971
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant treatment with zoledronic acid after extensive curettage for giant cell tumours of bone.
Gouin F; Rochwerger AR; Di Marco A; Rosset P; Bonnevialle P; Fiorenza F; Anract P
Eur J Cancer; 2014 Sep; 50(14):2425-31. PubMed ID: 25088085
[TBL] [Abstract][Full Text] [Related]
7. PDGF receptor beta is a potent regulator of mesenchymal stromal cell function.
Tokunaga A; Oya T; Ishii Y; Motomura H; Nakamura C; Ishizawa S; Fujimori T; Nabeshima Y; Umezawa A; Kanamori M; Kimura T; Sasahara M
J Bone Miner Res; 2008 Sep; 23(9):1519-28. PubMed ID: 18410236
[TBL] [Abstract][Full Text] [Related]
8. Panax notoginseng saponins promotes proliferation and osteogenic differentiation of rat bone marrow stromal cells.
Li XD; Wang JS; Chang B; Chen B; Guo C; Hou GQ; Huang DY; Du SX
J Ethnopharmacol; 2011 Mar; 134(2):268-74. PubMed ID: 21167926
[TBL] [Abstract][Full Text] [Related]
9. Real-time quantitative RT-PCR analysis of human bone marrow stromal cells during osteogenic differentiation in vitro.
Frank O; Heim M; Jakob M; Barbero A; Schäfer D; Bendik I; Dick W; Heberer M; Martin I
J Cell Biochem; 2002; 85(4):737-46. PubMed ID: 11968014
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates may reduce recurrence in giant cell tumor by inducing apoptosis.
Chang SS; Suratwala SJ; Jung KM; Doppelt JD; Zhang HZ; Blaine TA; Kim TW; Winchester RJ; Lee FY
Clin Orthop Relat Res; 2004 Sep; (426):103-9. PubMed ID: 15346059
[TBL] [Abstract][Full Text] [Related]
11. Zoledronate, ibandronate and clodronate enhance osteoblast differentiation in a dose dependent manner--a quantitative in vitro gene expression analysis of Dlx5, Runx2, OCN, MSX1 and MSX2.
Koch FP; Merkel C; Al-Nawas B; Smeets R; Ziebart T; Walter C; Wagner W
J Craniomaxillofac Surg; 2011 Dec; 39(8):562-9. PubMed ID: 21030265
[TBL] [Abstract][Full Text] [Related]
12. Anti-angiogenic property of zoledronic acid by inhibition of endothelial progenitor cell differentiation.
Yamada J; Tsuno NH; Kitayama J; Tsuchiya T; Yoneyama S; Asakage M; Okaji Y; Shuno Y; Nishikawa T; Tanaka J; Takahashi K; Nagawa H
J Surg Res; 2009 Jan; 151(1):115-20. PubMed ID: 18619615
[TBL] [Abstract][Full Text] [Related]
13. Bisphosphonates hinder osteoblastic/osteoclastic differentiation in the maxillary sinus mucosa-derived stem cells.
Zhang J; Park J; Lee JW; Kwon YD; Kim EC
Clin Oral Investig; 2018 Jun; 22(5):1933-1943. PubMed ID: 29188452
[TBL] [Abstract][Full Text] [Related]
14. PTHrP increases RANKL expression by stromal cells from giant cell tumor of bone.
Cowan RW; Singh G; Ghert M
J Orthop Res; 2012 Jun; 30(6):877-84. PubMed ID: 22102368
[TBL] [Abstract][Full Text] [Related]
15. Identification of the GATA factor TRPS1 as a repressor of the osteocalcin promoter.
Piscopo DM; Johansen EB; Derynck R
J Biol Chem; 2009 Nov; 284(46):31690-703. PubMed ID: 19759027
[TBL] [Abstract][Full Text] [Related]
16. Enhanced Osteogenic Differentiation in Zoledronate-Treated Osteoporotic Patients.
Dalle Carbonare L; Mottes M; Malerba G; Mori A; Zaninotto M; Plebani M; Dellantonio A; Valenti MT
Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28608802
[TBL] [Abstract][Full Text] [Related]
17. The effects of zoledronate on the survival and function of human osteoblast-like cells.
Huang KC; Cheng CC; Chuang PY; Yang TY
BMC Musculoskelet Disord; 2015 Nov; 16():355. PubMed ID: 26572124
[TBL] [Abstract][Full Text] [Related]
18. In Vitro Study of the Effects of Denosumab on Giant Cell Tumor of Bone: Comparison with Zoledronic Acid.
Shibuya I; Takami M; Miyamoto A; Karakawa A; Dezawa A; Nakamura S; Kamijo R
Pathol Oncol Res; 2019 Jan; 25(1):409-419. PubMed ID: 29159783
[TBL] [Abstract][Full Text] [Related]
19. Tenuigenin promotes the osteogenic differentiation of bone mesenchymal stem cells in vitro and in vivo.
Jiang HJ; Tian XG; Huang SB; Chen GR; Huang MJ; Chen YH; Yan B; Li SF; Tang JJ; Zhao HY; Wang L; Zhang ZM
Cell Tissue Res; 2017 Feb; 367(2):257-267. PubMed ID: 27844205
[TBL] [Abstract][Full Text] [Related]
20. The role of TWIST as a regulator in giant cell tumor of bone.
Singh S; Mak IW; Cowan RW; Turcotte R; Singh G; Ghert M
J Cell Biochem; 2011 Sep; 112(9):2287-95. PubMed ID: 21503964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
